After revisiting the "wildling" mouse data this weekend, I’ve lost a lot of faith in our current screening pipelines. It’s becoming clear that we aren’t actually studying aging; we’re studying how a creature recovers from the side effects of extreme domestication.

Look at the standard lab mouse. It’s tucked away in a sterile SPF bubble, fed a predictable starch diet, and shielded from any real social or environmental stress. When a compound like Rapamycin or a Sirtuin activator kicks back a 20% lifespan bump, I’m not sure we’re actually slowing down biological entropy. It’s more likely we’re just counteracting the metabolic bloat of an animal living in a vacuum.

The human microbiome is a mess—a high-stakes, competitive landscape. Our guts churn out metabolites like TMAO and p-cresol that harden our arteries and fuel inflammation for decades. In contrast, the lab mouse’s microbial engine is basically idling in a climate-controlled garage. We’re fine-tuning a car that’s never hit a pothole and acting surprised when the tires fail on a real road.

If our baseline "old" mouse is really just a metabolic artifact, then most longevity drugs we’ve found are probably just fixes for lab-induced quirks. We aren’t measuring the organism itself; we’re measuring the shadow of something that doesn't exist in the wild. We’ve fallen into a proxy trap, optimizing for the survival of a sheltered genotype instead of the resilience of a real phenotype.

That’s why the translation gap is so massive. The problem isn't necessarily that the biology doesn't translate—it’s that the mouse wasn't "old" in an evolutionary sense. It was just stagnant.

We don't need the 500th iteration of a C57BL/6 study. We need "dirty" models and wild-derived cohorts that face the same microbial and environmental friction humans do. If a molecule can’t hold up against a complex microbiome and a changing environment, it isn't a longevity breakthrough. It’s a pet supplement.

I want to find collaborators who are ready to step outside the SPF bubble. We need a real push toward wildling-based screening. I'm done winning a rigged game; let's see what these drugs can actually do.